Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Optimal preoperative multidisciplinary treatment in borderline resectable pancreatic cancer: Results of a dual-center study.
Authors
Nana Kimura
Department of Surgery and Science Faculty of Medicine, Academic Assembly University of Toyama, Toyama, Japan
Nana Kimura , Suguru Yamada , Hideki Takami , Kenta Murotani , Isaku Yoshioka , Kazuto Shibuya , Fuminori Sonohara , Yui Hoshino , Katsuhisa Hirano , Toru Watanabe , Hayato Baba , Kosuke Mori , Takeshi Miwa , Haruyoshi Tanaka , Mitsuro Kanda , Masamichi Hayashi , Koshi Matsui , Tomoyuki Okumura , Yasuhiro Kodera , Tsutomu Fujii
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
DOI
10.1200/JCO.2022.40.4_suppl.530
Abstract #
530
Poster Bd #
F1
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Overall survival with preoperative biliary drainage in patients with resectable pancreatic cancer.
First Author: Tobin Joel Crill Strom
Poster
2024 ASCO Breakthrough
Clinical determinants of survival in patients with stage II-III pancreatic cancer.
First Author: Haruka Itakura
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Factors associated with the receipt of surgery in acinar cell carcinoma of the pancreas.
First Author: Jasleen Kaur Chaddha
Poster
2024 ASCO Gastrointestinal Cancers Symposium
New cutoff of CA19-9 values for predicting pancreatic cancer using liquid biopsy.
First Author: Ryuji Hasebe